Cardiogenic pulmonary edema

Article written and reviewed by Dr Luca Moretti

Cardiogenic pulmonary edema is the acute or subacute accumulation of fluid in the interstitium and alveoli due to an increase in pulmonary capillary hydrostatic pressure of cardiac origin. It is a phenotype of acute heart failure and a time-sensitive respiratory syndrome, not a definitive etiological diagnosis: ischemia, hypertensive crisis, acute valvular disease, arrhythmia or volume overload require different interventions. The presentation may develop through progressive sodium and water accumulation or rapid blood redistribution from the splanchnic compartment to the thorax. In the latter case, typical of hypertensive edema, dyspnea may develop within minutes with minimal weight gain, preserved ejection fraction and no marked increase in total volume. The simultaneous priorities are to support oxygenation and ventilation, reduce filling pressures and identify the reversible cause; treatment begins on the basis of clinically evident physiology without waiting for all investigations to be completed.

Cardiogenic edema must be distinguished from ARDS, pneumonia, aspiration, alveolar hemorrhage, neurogenic edema, isolated renal failure and increased-permeability forms. The two physiologies may coexist, especially in sepsis, myocardial infarction, transfusion or ventilation; a single B-line or an elevated BNP does not establish the cause. Severity ranges from interstitial congestion with exertional dyspnea to alveolar flooding with froth, hypoxemia, hypercapnia and fatigue. Neurological impairment, oliguria and elevated lactate are signs of possible hypoperfusion; hypotension may be present but is not sufficient on its own to define shock, which requires an integrated assessment of perfusion. Prognosis depends more on the substrate, precipitant and organ injury than on radiological resolution. Even after rapid respiratory improvement, completion of decongestion, etiological treatment and prevention of recurrence remain necessary.

Etiology, pathogenesis and pathophysiology

Fluid movement across the alveolar-capillary barrier is governed by hydrostatic and oncotic gradients, permeability and lymphatic drainage. When capillary pressure exceeds lymphatic capacity, fluid first moves into the septa and peribronchovascular spaces, then into the alveoli; the Starling equation describes this process, now incorporating the role of the endothelial glycocalyx. In chronic states, lymphatic drainage may adapt and delay edema at high pressures; an abrupt increase does not allow adaptation and produces severe symptoms at values lower than those tolerated by chronically congested patients. Alveolar fluid clearance depends on active sodium transport and epithelial integrity. Ischemia, inflammation and injurious ventilation may slow it, explaining why resolution is not immediate after hemodynamic correction.

Acute hypertension increases afterload and wall stress, slows relaxation and raises left atrial pressure. Sympathetic stimulation constricts the splanchnic vascular bed and transfers volume to the thorax; the SCAPE phenotype, or sympathetic crashing acute pulmonary edema, combines very high blood pressure, respiratory distress and rapid redistribution. HFpEF, hypertrophy and aortic stenosis make filling pressure extremely sensitive to tachycardia and afterload; a normal ejection fraction does not protect against congestion and does not change the respiratory urgency. In HFrEF, reduced contractility, mitral regurgitation and increased volume contribute in varying proportions; a sudden increase in functional regurgitation during ischemia or elevated pressure may precipitate edema before a large change in ejection fraction.

Acute coronary syndrome causes systolic or diastolic dysfunction, papillary muscle ischemia and arrhythmias. A mechanical complication, such as papillary muscle rupture, a septal defect or acute mitral regurgitation, may cause pulmonary hypertension and instability and requires urgent correction; a giant v wave may appear in acute mitral regurgitation. Acute aortic regurgitation, critical stenosis, endocarditis, prosthetic thrombosis or dysfunction are valvular causes. In acute mitral regurgitation, the nondilated atrium cannot accommodate the volume and edema may be asymmetric, sometimes predominantly right-sided. Myocarditis, Takotsubo syndrome and cardiotoxicity may present with edema; the history and imaging determine the pathway after stabilization.

Rapid atrial fibrillation, flutter, ventricular tachycardias and bradyarrhythmias reduce filling and cardiac output. In a stiff ventricle, loss of atrial systole and shortened diastole rapidly raise pressure; rhythm restoration may be the treatment directed at the cause. A renal crisis, missed dialysis, excess sodium or diuretic withdrawal produces sodium and water overload. Drugs such as NSAIDs, thiazolidinediones and some calcium channel blockers promote retention or edema and must be recognized. Infection, anemia, thyrotoxicosis and embolism increase demand or load. There is often more than one precipitant, and the search does not stop at the first plausible finding.

Increased interstitial pressure reduces lung compliance, increases the work of breathing and stimulates juxtacapillary receptors; peribronchial edema narrows the airways and may produce wheezing, known as cardiac asthma, without implying primary bronchospasm. Alveolar fluid causes shunting and hypoxemia; in the early stages, tachypnea produces hypocapnia, while hypercapnia signals fatigue, severe obstruction or a reduced level of consciousness. Acidosis increases pulmonary pressure and cardiac work. Positive pressure improves recruitment and reduces venous return and left ventricular afterload, but may decrease cardiac output in hypovolemic patients or those with right-sided failure.

The congested lung releases mediators and may develop barrier injury; the distinction between hydrostatic and permeability mechanisms is therefore a continuum. Sepsis, aspiration and transfusions may superimpose ARDS or TRALI on a heart with elevated pressures; pleural effusions result from increased filtration and are often bilateral or right-sided. A unilateral effusion, fever or pain requires assessment for an alternative diagnosis and sometimes thoracentesis; reactive pulmonary hypertension increases right ventricular load. In severe edema, hypoxia and ventilation may produce biventricular dysfunction and worsen perfusion.

Clinical manifestations

Dyspnea develops rapidly, with orthopnea, cough, anxiety and a sense of suffocation; the patient sits upright, speaks in single words, uses accessory muscles and is diaphoretic; pink, frothy sputum is suggestive but not necessary. Tachypnea, tachycardia, hypoxemia and diffuse crackles are frequent; cardiac wheezing may predominate and incorrectly lead to treatment for asthma or COPD alone. Cold skin, confusion, low blood pressure and oliguria indicate hypoperfusion. High blood pressure points toward the vascular phenotype, but may fall after exhaustion or treatment.

Initial blood pressure guides treatment. In hypertensive edema, it is often above 160-180 mmHg; in the normotensive profile, volume and the cause predominate, while in the hypotensive profile, vasodilators and aggressive diuresis may worsen cardiac output. Examination assesses jugular veins, a third heart sound, murmurs, edema and perfusion; the absence of peripheral edema supports redistribution but does not rule out cardiac congestion. A new murmur, pulse differences, pain or fever suggests a mechanical complication, dissection or endocarditis; these findings immediately change investigations and treatment.

Chest pain may indicate myocardial infarction, dissection or increased demand; palpitations suggest arrhythmia; edema during an infusion, transfusion or dialysis requires distinguishing overload, anaphylaxis and transfusion-related lung injury. Fever and focal infiltrates increase the probability of infection, but leukocytosis and temperature elevation may reflect stress; the differential diagnosis remains dynamic after initial stabilization. In older patients, agitation or delirium may precede the description of dyspnea. Obesity and COPD make signs and radiography less specific.

The initial response is assessed within minutes: respiratory rate, work of breathing, saturation, blood pressure, consciousness and blood gases; rapid reduction of respiratory distress with CPAP and vasodilation supports cardiogenic physiology but is not absolute etiological proof. Failure is indicated by persistent hypoxemia, rising hypercapnia, exhaustion, instability or inability to protect the airway; intubation must not be delayed by prolonged NIV attempts. After improvement, jugular veins, B-lines, weight and urine output define residual congestion. Resolution of anxiety does not equate to complete decongestion.

Unilateral or asymmetric edema may occur with eccentric mitral regurgitation, lateral positioning or vascular disease, but pneumonia and hemorrhage are more common and must be excluded. Serial chest radiography helps if the clinical picture is discordant; recurrent “flash” edema with hypertension and apparently preserved function suggests bilateral renal artery stenosis, valvular disease, ischemia or pheochromocytoma in selected settings. Nocturnal episodes may result from redistribution in the supine position, apnea and insufficient blood pressure control; prevention requires defining the mechanism, not merely increasing the diuretic.

Investigations and diagnosis

Diagnosis and treatment proceed together. An ECG obtained within minutes looks for ischemia, arrhythmia and overload; oxygen saturation, blood gas analysis in severe cases, complete blood count, electrolytes, creatinine, glucose, liver tests, troponin and peptide levels define severity and precipitants. Low BNP or NT-proBNP makes heart failure less likely, but obesity reduces their levels and extremely rapid edema may precede a large increase. Age, renal dysfunction and atrial fibrillation elevate them; the contextual value takes precedence over an isolated threshold. Troponin may increase because of myocardial infarction or stress injury; diagnosis of myocardial infarction requires a change and evidence of ischemia, not the biomarker alone.

Lung ultrasound shows multiple, diffuse, bilateral B-lines, a generally thin and regular pleural line and frequent effusions. It is more sensitive than radiography for congestion, but B-lines also occur in interstitial lung disease, ARDS, pneumonia and contusion; distribution and the pleura help distinguish them. B-line quantification follows protocols with 4, 8 or more zones and must be consistent during follow-up; a reduction accompanies decongestion but is not the only therapeutic goal. Focal consolidations with air bronchograms, an irregular pleura or spared areas point toward infection or increased permeability. Pneumothorax can be rapidly excluded in experienced hands.

Bedside echocardiography assesses left and right ventricular function, valves, the pericardium, aorta and volume. New mitral regurgitation, a septal defect, tamponade or prosthetic dysfunction requires urgent imaging and a dedicated team; Doppler estimation of filling pressure is imperfect in the acute setting and depends on rhythm and valves. Findings are integrated with the atrium, vena cava, lungs and response. Transesophageal echocardiography is indicated when the critical question is not resolved by transthoracic imaging, especially for valves, endocarditis, dissection or postoperative complications.

Chest radiography shows vascular redistribution, Kerley lines, peribronchial cuffing, perihilar opacities and effusions. It may initially be normal or difficult to interpret in the supine position; radiological resolution lags behind clinical resolution. CT is not a routine examination in an unstable patient, but clarifies embolism, dissection, pneumonia or atypical edema after stabilization; coronary angiography is urgent when criteria for coronary syndrome or ischemic instability are present. Cultures, CRP and procalcitonin are used if infection is suspected. Antibiotics are not indicated solely for bilateral cardiogenic infiltrates.

Right heart catheterization is reserved for shock, uncertain physiology, failure to respond or advanced therapies; elevated wedge pressure supports the hydrostatic mechanism, but measurement and v waves require correct technique; the value may normalize after treatment. The differential diagnosis with ARDS uses context, lung ultrasound, echocardiography, biomarkers and the course; a low PaO2/FiO2 ratio measures the severity of hypoxemia, not the origin of the fluid. The final assessment must name the etiology, precipitant and phenotype: hypertensive, normotensive, hypoperfused, valvular, ischemic, arrhythmic or due to overload. This description guides prevention and follow-up.

Treatment and prognosis

The patient is positioned sitting up, monitored and treated with venous access, continuous ECG and repeated measurements. Oxygen is indicated in hypoxemia, not routinely when saturation is adequate; excess oxygen may cause vasoconstriction and does not correct respiratory mechanics. CPAP or noninvasive ventilation is initiated early for respiratory distress, a high respiratory rate or hypoxemia if the patient is cooperative and protects the airway. Positive pressure improves dyspnea and acidosis more rapidly, although it did not demonstrate a clear mortality advantage in 3CPO. Arrest, vomiting, facial trauma, severe impairment of consciousness or instability are relative or absolute contraindications. Intubation requires preparation because sedation and positive pressure may cause collapse.

In hypertensive edema, rapidly titrated intravenous nitrates reduce preload and afterload. Initial doses and infusion rates depend on blood pressure and protocols; hypotension, right ventricular infarction and critical aortic stenosis require caution, while recent use of PDE5 inhibitors contraindicates nitrates for the interval specified for the active agent. The goal is controlled reduction of blood pressure and work, not instantaneous normalization; early vasodilation is often more important than diuresis when redistribution predominates. Nitroprusside is a monitored option in high afterload and acute regurgitation, with attention to renal function, toxicity and ischemia. Morphine is not routine therapy because of the risk of respiratory depression and worse observational outcomes.

Loop diuretics are indicated with volume overload or congestion. In patients already receiving treatment, the initial intravenous dose must be proportional to the home dose; response is assessed through urine output, urinary sodium, symptoms, renal function and electrolytes. An insufficient response requires rational dose doubling or sequential nephron blockade, not delayed repetition of ineffective doses. Acetazolamide may increase decongestion in selected patients with acute overload. In purely redistribution-related edema without volume excess, high doses may cause hypovolemia after vasodilation; serial examination distinguishes the phenotypes.

The cause is treated simultaneously. Coronary syndrome requires a revascularization pathway; a mechanical or valvular complication requires a Heart Team and often urgent surgery or intervention; an unstable arrhythmia requires cardioversion. Hypertensive emergency, infection, thyrotoxicosis, anemia and renal failure receive specific treatment. Dialysis or ultrafiltration is used for renal indications or refractory overload, not as an automatic substitute for diuretics. In hypotension with hypoperfusion, norepinephrine and an inotrope may be necessary; nitrates are avoided and the shock pathway, including hemodynamic assessment and support, is applied.

Chronic beta-blockers are not automatically discontinued if the patient is perfused, but bradycardia, shock or a need for inotropes requires reassessment. RAAS inhibitors, MRAs and SGLT2 inhibitors are managed according to blood pressure, renal function, potassium and procedures and resumed after stabilization when indicated. Before discharge, clinical euvolemia is achieved, an effective oral dose is defined and the precipitant corrected. Residual congestion, including on ultrasound, predicts recurrence but must be balanced against tolerance. Education on weight, blood pressure, sodium, medications and emergencies, and early follow-up reduce risk; simply prescribing more diuretic does not prevent a new hypertensive or valvular episode.

Immediate mortality is influenced by age, myocardial infarction, low blood pressure, renal function, troponin, right ventricular function and the need for intubation; rapid improvement in hypertensive edema does not eliminate the underlying cardiovascular risk. Repeated hospitalizations indicate worsening heart failure and require treatment review and advanced assessment; prognosis is better if the cause is rapidly reversible and no organ injury is present. The quality of the transition matters: reconciliation, laboratory monitoring, management of valves and ischemia, and timely access prevent a syndrome resolved in the emergency department from remaining without treatment of its cause.

Complications

Respiratory failure may progress to hypercapnia, loss of consciousness and arrest. Late intubation increases aspiration and instability, while an unprepared procedure may precipitate shock through vasodilation and reduced venous return. High-pressure ventilation causes barotrauma and reduces cardiac output. The risk of ventilator-associated lung injury is reduced through a protective ventilation strategy, including limited tidal volumes and individualized PEEP after intubation. Pneumonia, aspiration and delirium complicate hospitalization, especially in older patients. Early mobilization and weaning reduce iatrogenic harm.

Cardiogenic shock may follow myocardial infarction, acute valvular disease or exhaustion of the hypertensive phenotype. Rising lactate, oliguria and cold skin require escalation before extreme hypotension. Atrial and ventricular arrhythmias are both a cause and a complication. Hypoxia, acidosis and potassium and magnesium disturbances increase electrical risk. Demand-related myocardial ischemia may elevate troponin, while a true occlusion requires reperfusion; the distinction is updated through ECG and the course.

Acute kidney injury may result from congestion, hypoperfusion, contrast or treatment. A moderate creatinine increase during effective decongestion does not automatically require leaving the patient congested; oliguria and perfusion signs modify its significance. Hyponatremia, hypokalemia or hyperkalemia and alkalosis complicate diuretic therapy and neurohormonal processes; serial monitoring is necessary during combined strategies. Hypoxic hepatitis and coagulopathy develop in shock or severe right-sided congestion and worsen prognosis.

Recurrent edema causes rehospitalization, decline and frailty. Each episode may reflect progression of valvular, ischemic or renal disease and must prompt a new etiological assessment. Persistent effusions may compress the lung; thoracentesis is reserved for large symptomatic effusions, diagnostic uncertainty or failure to respond; routine drainage of a small transudate is unnecessary. Incomplete decongestion maintains pulmonary pressure and right ventricular dysfunction; excessive decongestion causes orthostatic hypotension, renal impairment and falls; the therapeutic window must be reassessed after discharge.

Drug complications include nitrate-induced hypotension, nitroprusside toxicity, opioid-induced depression and diuretic-related disturbances. Protocols and frequent reassessment reduce errors in a syndrome that evolves within minutes; mechanical complications of myocardial infarction may initially be masked by respiratory noise. An absent murmur does not rule out acute mitral regurgitation when atrial pressure equalizes rapidly. In the terminal phase, repeated episodes may require a palliative plan for dyspnea and place of care, integrated with active treatment and decisions about ventilation and resuscitation.